Advance Innovative Therapies with Pioneering Nanodelivery Technologies
Revolutionizing Gene Therapy with Advanced Lipid Nanoparticle Solution
RNA Sequence Design
In Vitro RNA Transfection with Lipid Nanoparticle Technology
In Vivo Targeting RNA Delivery with Lipid Nanoparticle Technology
Innovative Lipid Nanoparticle Solutions
Advancing lipid nanoparticle technology for safer and effective drug delivery and therapies.
Our team, supported by extensive academic and industry expertise, has successfully launched Satreda LNP, a proprietary series of transfection vector products. Designed to enhance cell and gene therapies, Satreda LNP offers advanced solutions for these cutting-edge treatments.
Our development pipeline is focused on delivering innovative treatments, with particular emphasis on localized LNP applications, such as for inhalation, intradermal use, and targeted delivery, including targeting the liver or lungs. We are also deeply invested in gene therapies, including RNA transfection in stem cells and primary stem cells, as well as utilizing CRISPR technology for gene editing. We are committed to developing differentiated therapies that offer significant clinical benefits and improve patient outcomes.
Satreda Pharmaceutical is a leading R&D company specializing in nanocarrier technology, with a strong focus on independent innovation. By combining the precision of molecular simulations with the reliability of empirical data, our research has resulted in the development of an advanced LNP platform. This platform is designed to overcome the complex challenges of siRNA and mRNA delivery, both in vitro and in vivo.